Fig. 3From: 3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trialsForest plot for comparison of 3,4-diaminopyridine treatment versus placebo, change in mean QMG scores with generalised inverse variance model (assumed r = 0.5 for within-patient treatment effects in cross-over trials)Back to article page